On July 10, 2025, IceCure Medical Ltd. announced the commencement of its previously disclosed rights offering. The company is distributing non-transferable subscription rights to all holders of record of its ordinary shares as of July 9, 2025. The offering aims to raise up to an aggregate of $10 million in gross proceeds.
Each subscription right entitles the holder to purchase 0.1703 of a unit, with each unit comprising one ordinary share and a warrant to purchase one ordinary share, at a subscription price of $1.00 per unit. Alternatively, holders can subscribe for a unit comprised of a pre-funded warrant and a warrant at $0.9999 per unit. The subscription period is set to expire on July 28, 2025.
Epoch Partner Investments Limited, IceCure's largest shareholder, has committed to participate in the rights offering, exercising its full subscription right and any over-subscription privilege, for an aggregate subscription price of up to $5 million. The proceeds are intended to repay a $2 million bridge loan from Epoch and for general corporate and working capital purposes, strengthening the company's financial position.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.